Open Access Open Access  Restricted Access Subscription or Fee Access

EFFECTS OF HORMONAL THERAPY ON POST MENOPAUSAL WOMEN IT: A REVIEW ARTICLE

Diwakaran Chitra, Pawan Kumar Sharma, Amrita Akhilesh Sivasanker

Abstract


Objectives: To replace the estrogen that your body stops making during menopause and allow women who choose therapies such as hormone replacement therapy and have taken much interest in improving lifestyle during postmenopausal period. For the benefit of women’s health in relation to hormone replacement treatment and its impact on the body and mind as well as cognitive support and functions in postmenopausal women has been shifting dramatically over the last decade bringing significant changes in a woman’s cognitive ability improving the quality of life for a postmenopausal women.
Materials and Methods: There were relevant studies for the topic which were reviewed. The previous research content that were gathered for the review were read thoroughly found postive effects on hormonal therapy on the post menopausal women which were gathered for the study. The sources for collection for the information were PubMed, CINAHAL, MEDLINE from information center on websites: The availability of document was accessible with full texts. Included research studies on related topic were collected from 2015 onwards till 2021. Search Criteria Results and Discussion Secondary outcome assessment Safety assessment and compliance the safety assessment and compliance level were the methods used in the study design.The level of serum were tested taking the baseline data culmination for the 12 weeks treatment period and it was found that there was significant difference between base line data analysis of the Chinese herbal medicine and its effects in the women particularly symptoms of disorder the Research report which was formulated contained the seventh compound of the time is medication herbal prescription which was used for the menopausal symptoms to control the nmenopausal syndrome displaying strong effects and increase the endocrine hormone helps in antioxidant functions with the help of aromatase and the knowledge which was used was for trial were the first control double blind trial clinically done to provide and make a standardized preparation which included capsules among the placebo group for the control group. The effects of HRT on bone mass, mineral density, and endocrine disorders, as well as its impact on postmenopausal women, were discovered. A comparative study also was conducted to check the effects of HRT on bone mass using combined method with oral contraceptive therapy. The usage of contraceptive pill for women with ovarian failure and assessed for the risk of HRT on the effects of bone density on women on HRT were
studied in women with breast cancer. Conclusion: The conclusion drawn for these studies were explaining about the risk and benefits of the estrogen on women who were assessed for the better results of the therapy under the health program WHI (Women health initiatives). The association of
HRT were found to be showing the incidence of breast cancer among those women an associated were incidences were recorded, and long-term
follow up were carried for better outcome. A ,premenopausal preoperative check for women was carried out to prevent the postoperative preventing
the risk of low hormone on the women who were undergoing salpingo-oophorectomy.


Full Text:

PDF

References


Marian IR et al. Hand Osteoarthritis: Investigating pain effects of estrogen-containing therapy (HOPE-e): A protocol for a feasibility randomised placebo-controlled trial. Pilot and Feasibility Studies. 2021; 7(1): 1–14. Available at: DOI: 10.1186/s40814–021–00869–1.

Cartwright B et al. Hormone replacement therapy versus the combined oral contraceptive pill in premature ovarian failure: A randomized controlled trial of the effects on bone mineral density.

Journal of Clinical Endocrinology and Metabolism. 2016; 101(9): 3497–3505. Available at: DOI:10.1210/jc.2015–4063.

Gazarra LBC et al. Bone mass in women with premature ovarian insufficiency: A comparative study between hormone therapy and combined oral contraceptives. Menopause (New York,N.Y.), 2020; 27(10): 1110–1116. Available at: DOI: 10.1097/GME.0000000000001592.

Manson JE et al. Menopausal hormone therapy and long-term all-cause and cause-specific mortality: The women’s health initiative randomized trials. Obstetrical and Gynecological Survey.

; 73(1): 22–24. Available at: DOI: 10.1097/01.ogx.0000527868.87744.14.

Beverly R, Volkar J. (2021). Risks and benefits of estrogen plus progestin in healthy postmenopausal women. 50 studies every obstetrician-gynecologist should know. 2018; 288(3):

–266. Available at: DOI:10.1093/med/9780190947088.003.0048.

Cao XJ et al. A randomized, double-blind, placebo-controlled trial of Chinese herbal medicine capsules for the treatment of premature ovarian insufficiency. Menopause. 2018; 25(8): 918–926.

Available at: DOI: 10.1097/GME.0000000000001099.

Prentice RL et al. Randomized trial evaluation of benefits and risks of menopausal hormone therapy among women aged 50–59 years of age. American Journal of Epidemiology. 2021;

(3): 365–375.

Chlebowski RT et al. Association of menopausal hormone therapy with breast cancer incidence and mortality during long-term follow-up of the women’s health initiative randomized clinical trials. JAMA-Journal of the American Medical Association. 2020; 324(4): 369–380. Available at:DOI: 10.1001/jama.2020.9482.

Yu X et al. Hormone replacement therapy and breast cancer survival: A systematic review and meta-analysis of observational studies. Breast Cancer. 2017; 24(5): 643–657. Available at: DOI:

1007/s12282–017–0789–5.

Zhu L et al. Knee osteoarthritis and menopausal hormone therapy in postmenopausal women: A nationwide cross-sectional study. Menopause. 2019; 23(4): 927–938. Available at: DOI: 10.1515/hmbci-2018–0019.

Sullivan SD et al. Age of menopause and fracture risk in postmenopausal women randomized to

calcium + Vitamin D, hormone therapy, or the combination: Results from the women’s health initiative clinical trials. Menopause. 2017; 24(4): 371–378. Available at: DOI:

1097/GME.0000000000000775.

Deli T, Orosz M, Jakab A. hormone replacement therapy in cancer survivors: Review of the Literature. Pathology and Oncology Research. 2020; 26(1): 63–78. Available at: DOI:

1007/s12253–018–00569–x.

Laakkonen EK, et al. Estrogenic regulation of skeletal muscle proteome: A study of premenopausal women and postmenopausal MZ cotwins discordant for hormonal therapy. Aging

Cell. 2017; 16(6): 1276–1287. Available at: DOI: 10.1111/acel.12661.

Ruan X, Mueck AO. The choice of progestogen for HRT in menopausal women: Breast cancer risk is a major issue. Hormone Molecular Biology and Clinical Investigation. 2019; 37(1): 1–12.

Available at: DOI: 10.1515/hmbci–2018–0019.

Tucker PE et al. The effects of pre-operative menopausal status and hormone replacement therapy (HRT) on sexuality and quality of life after risk-reducing salpingo-oophorectomy. Maturitas.

; 85: 42–48. Available at: DOI: 10.1016/j.maturitas.2015.12.004.




DOI: https://doi.org/10.37628/ijgn.v8i1.2156

Refbacks

  • There are currently no refbacks.